Joseph Gjolaj, MD
Orthopaedic Surgery · Miami, FLNPI 1578609137
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $84,553 of the $104,845 with a category attached, or 80.6%. 13 manufacturers reported payments, led by Medical Device Business Services, Inc. at 30.6% of the total.
Across 231 payments — averaging $453.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$32K
- Globus Medical$21K
- Carl Zeiss Meditec USA, Inc.$18K
- Cerapedics Inc.$17K
- Carlsmed, Inc.$9K
- Silony Medical Corp.$6K
- plus $2K from 7 others
Across 30 payments — averaging $994.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$30K
What the payments were for
- Consulting fees$84,55381%
- Speaking & faculty fees$7,8848%
- Travel & lodging$6,1836%
- Food & beverage$6,1266%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 33 | $32,131 |
| Globus Medical(2 entities) | 71 | $20,795 |
| Carl Zeiss Meditec USA, Inc. | 8 | $18,371 |
| Cerapedics Inc. | 11 | $17,118 |
| Carlsmed, Inc. | 85 | $8,726 |
| Silony Medical Corp. | 6 | $5,890 |
| Stryker | 6 | $590 |
| Johnson & Johnson(3 entities) | 4 | $531 |
| Pacira Pharmaceuticals Incorporated | 3 | $384 |
| VB Spine LLC | 1 | $235 |
| Ossdsign USA Incorporated | 1 | $47 |
| Solventum Corporation | 1 | $14 |
| Alafair Biosciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPEDIUM$31,008
- VIPER$30,903
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$16,800
- OPMI PENTERO 800$10,836
- XLIF$9,118
- aprevo$6,750
- RELINE$2,520
- VuePoint$2,274
- ExcelsiusGPS Robotic Navigation System$1,062
- LessRay$936
- TLIF$746
- EXPAREL$292
- ESCALATE$235
- ACP$173
- MONTEREY AL$161
- SERRATO$139
- Pulse$136
- POWER$136
- FIBERGRAFT BG Morsels$101
How this compares
$104,845 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 226 | $4,330 |
| Gabapentin | 216 | $2,775 |
| Vancomycin Hcl | 58 | $2,070 |
| Pregabalin | 26 | $434 |
| Duloxetine Hcl | 23 | $431 |
| Sodium Chloride0.9 % Sodium Chloride | 27 | $396 |
| Diclofenac Sodium | 13 | $259 |
| Methylprednisolone | 23 | $160 |
| Meloxicam | 39 | $72 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Miami
- Charles LawrieMiami$1.7M
- Rolando GarciaMiami$1M
- Charles JordanMiami$817K
- Francis HornicekMiami$790K
- Aldo RiesgoMiami$709K
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.